Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Trends & Forecasts

Business & Regulation Trends & Forecasts

Inside the World’s Most Expensive Pharmaceutical Market

| Maryam Mahdi

As US prices for Rx drugs continues to rise, patients are finding themselves priced out of access to much-needed medicines.

Business & Regulation Digital Technologies

How the Industrial Internet of Things is Transforming Bioprocessing

| Sponsored by GE Healthcare

Digitalization means a more productive and adaptive plant through the application of analytics to leverage connectivity and data.

Business & Regulation Trends & Forecasts

We Must Focus on Science, Not Geography

| Steve Arlington

In times of political and social upheaval, maintaining our links across borders and working closely together is more important than ever.

Business & Regulation Trends & Forecasts

Are You Suffering from Brexit Fatigue?

| James Strachan

The uncertainty surrounding the UK’s future with Europe is having a measurable effect on pharma. But it looks like the end is nowhere in sight.

Business & Regulation Trends & Forecasts

2023: Prices and Predictions

| Maryam Mahdi

How will the industry shape up over the next five years?

Business & Regulation Trends & Forecasts

Aid Africa

| Stephanie Sutton

Healthcare, fake medicines, and the need for new antibiotics – a round-up from the UK East Africa Health Summit.

Manufacture Trends & Forecasts

Under Construction: Pharma's Cannabinoid Bid

| James Strachan

The cannabis business is booming as century-old legal conventions restricting use begin to unravel. Can pharma ride the wave?

Business & Regulation Trends & Forecasts

Ask, and Ye Shall Receive

| James Strachan

Regardless of how Britain leaves the European Union, the global pharma industry must always lobby for positive change.

Business & Regulation Trends & Forecasts

Mergers and Big Decisions

| George Chressanthis, Randy Risser

Why the CVS-Aetna merger could be a transformative event for the pharmaceutical industry.

Business & Regulation Trends & Forecasts

Medicine Making in Europe

| Stephanie Sutton

EFPIA figures give a snapshot of drug development and innovation in Europe. Check out our infographic for some of the key stats.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register